Project Grant R03DA065200
- Federal Grant Award Summary Yale University received a $357,613 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 1, 2025, through May 31, 2027. The award funds a research initiative titled "Finding the Missing Parts of Human Genetics of Substance Use Disorders," which leverages large-scale whole-genome sequencing (WGS) data from publicly available biobanks, including the All of Us...
- Federal Grant Award Summary Yale University received a $2.26 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded March 1, 2026, with completion targeted for February 28, 2030. The award funds research to characterize genetic effects on molecular phenotypes at single-cell resolution across brain regions in the context of substance use disorder (SUD) and HIV comorbidity. The project leverages data from...
- Federal Grant Award Summary Yale University received a $1.38 million Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded June 1, 2025, with completion targeted for February 28, 2030. The project, titled "Applying a Multiple Methods Approach to Examine Spatial and Temporal Variability in a State's Illicit Drug Market," delivers integrated data collection and analysis on drugs circulating in Connecticut's...
- Federal Grant Award Summary Yale University received a $2.23 million Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), effective April 1, 2026 through February 28, 2031. The GEO IMPACT project deliverables include development and implementation of a learning public health system designed to increase reach and access to HIV and substance use disorder prevention, care, and treatment services for people who use drugs (PWUD)...
- Federal Project Grant Award Summary Yale University received a $1,061,526 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded May 15, 2025, with completion targeted for April 30, 2027. The award supports the design and testing of SPARC (Substance use Prevention in Adolescents Receiving Clinical decision supports), a novel health equity-focused clinical decision support intervention integrated into pediatric...
- Federal Project Grant Award Summary Yale University received a $195,048 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 1, 2025 through August 31, 2030. This award supports the development of a culturally adapted Contingency Management (CM) intervention for adults with Stimulant Use Disorder in New Haven, Connecticut. CM is a behavioral economics-based intervention that uses tangible positive...
- Federal Grant Award Summary Yale University received a $3.14 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded May 1, 2025, with a completion date of February 28, 2030. The grant supports a comprehensive neuroimaging research initiative investigating kappa opioid receptors (KOR) in individuals with opioid use disorder (OUD) during early abstinence. The project delivers novel positron emission...
- Federal Grant Award Summary Yale University received a $197,024 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) on July 30, 2025, with a completion date of June 30, 2027. The grant funds two multi-methods research studies examining the impact of xylazine, a veterinary tranquilizer emerging as an adulterant in the unregulated opioid supply, on people who use drugs (PWUD). The first study, conducted in North...
- Federal Grant Award Summary Princeton University received a $164,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded August 15, 2025, with completion targeted for July 31, 2027. The award supports development of a Chemical Artificial Intelligence (AI) and Data Science Platform designed to identify and discover novel psychoactive substances (NPS). The project will deliver three primary products: (1) a...
- Federal Project Grant Award Summary Yale University received a $158,545 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective March 1, 2026 through February 29, 2028. This award supports the community pharmacy-based adaptation and pilot testing of integrated HIV and substance use disorder (SUD) care. The project, led by Dr. Tarfa (a pharmacist and health services researcher at Yale School of Medicine), addresses...
Yale University received a $336,250 project grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective April 1, 2026 through March 31, 2028. The award supports the development of a behavioral foundation model that leverages advanced natural language processing and large language models to transform qualitative epidemiological survey responses from the National Epidemiologic Survey on Alcohol and Related Conditions III (NESARC-III), National Survey on Drug Use and Health (NSDUH), and UK Biobank into quantitative, machine-interpretable representations of substance use behaviors. The research team will harmonize structured and free-text survey data into unified narratives, fine-tune state-of-the-art open-source large language models with integrated demographic tokens, and rigorously validate model performance using established metrics including area under the ROC curve, calibration analysis, and cross-dataset generalizability assessments. The project will deliver open-access tools and analytical capabilities designed to enable precision public health initiatives for substance use disorder prevention and intervention. Specific deliverables include risk stratification models for substance use disorder outcomes, latent clustering methodologies to identify distinct risk and resilience profiles, and data-driven optimization strategies for survey instrument design. These products will enhance early identification of high-risk populations and support targeted interventions to reduce the public health burden of substance use disorders.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $336.3k | 3/20/26 |